Skip to main navigation Skip to search Skip to main content

Nonparametric trend test for the cumulative tumor incidence rate

  • United States Food and Drug Administration

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The fundamental approach of Malani and Van Ryzin (JASA, 1988) is utilized to develop a nonparametric test for dose-related trend for use with tumorigenicity data from animal bioassays that include interim sacrifices. By constraining the age-specific tumor incidence rate to be nonnegative, the proposed procedure improves both the size and power of the Malani-Van Ryzin test. A real-data example and a small Monte Carlo simulation study illustrate the improvements achieved by the new test.

Original languageEnglish
Pages (from-to)1677-1692
Number of pages16
JournalCommunications in Statistics - Theory and Methods
Volume25
Issue number8
DOIs
StatePublished - 1996

Keywords

  • Bioassay
  • Constrained maximization
  • Delta method
  • Expected information
  • Interval sacrifice
  • Power
  • Size

Fingerprint

Dive into the research topics of 'Nonparametric trend test for the cumulative tumor incidence rate'. Together they form a unique fingerprint.

Cite this